中文版 | English

在结果中检索

HFCAS OpenIR

浏览/检索结果: 共3条，第1-3条 帮助

已选(0)清除 条数/页：   排序方式：
Improved clinical outcomes in advanced hepatocellular carcinoma treated with transarterial chemoembolization plus atezolizumab and bevacizumab: a bicentric retrospective study 期刊论文
BMC CANCER, 2023, 卷号: 23
作者:  Cao, Fei;  Shi, Changsheng;  Zhang, Guofu;  Luo, Jun;  Zheng, Jiaping;  Hao, Weiyuan
收藏  |  浏览/下载：10/0  |  提交时间：2023/11/10
Hepatocellular carcinoma  Atezolizumab  Bevacizumab  Overall survival  Progression-free survival  
Neoadjuvant immunotherapy in non-small-cell lung cancer: a narrative review on mechanisms, efficacy and safety 期刊论文
JOURNAL OF THORACIC DISEASE, 2022
作者:  Shao, Lan;  Lou, Guangyuan
收藏  |  浏览/下载：44/0  |  提交时间：2022/12/22
Neoadjuvant  immunotherapy  immune-checkpoint inhibitors  non-small cell lung cancer (NSCLC)  
Atezolizumab in combination with bevacizumab in patients with unresectable locally advanced or metastatic mucosal melanoma: Interim analysis of an open-label phase II trial. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Si, Lu;  Fang, Meiyu;  Chen, Yu;  Mao, Lili;  Zhang, Peng;  Lin, Jing;  Bai, Xue;  Cao, Xiao;  Chen, Yi;  Guo, Jun
收藏  |  浏览/下载：43/0  |  提交时间：2022/01/10